- Home
- CRON vs CSTL Comparison
CRON vs CSTL Comparison
Compare CRON & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRON
- CSTL
- Stock Information
- Founded
- CRON 2012
- CSTL 2007
- Country
- CRON Canada
- CSTL United States
- Employees
- CRON N/A
- CSTL N/A
- Industry
- CRON Medicinal Chemicals and Botanical Products
- CSTL Medical Specialities
- Sector
- CRON Health Care
- CSTL Health Care
- Exchange
- CRON Nasdaq
- CSTL Nasdaq
- Market Cap
- CRON 795.2M
- CSTL 848.1M
- IPO Year
- CRON N/A
- CSTL 2019
- Fundamental
- Price
- CRON $1.94
- CSTL $27.39
- Analyst Decision
- CRON Hold
- CSTL Strong Buy
- Analyst Count
- CRON 2
- CSTL 7
- Target Price
- CRON $3.00
- CSTL $37.57
- AVG Volume (30 Days)
- CRON 1.0M
- CSTL 315.1K
- Earning Date
- CRON 11-12-2024
- CSTL 11-04-2024
- Dividend Yield
- CRON N/A
- CSTL N/A
- EPS Growth
- CRON N/A
- CSTL N/A
- EPS
- CRON N/A
- CSTL 0.21
- Revenue
- CRON $111,229,000.00
- CSTL $311,878,000.00
- Revenue This Year
- CRON $35.84
- CSTL $51.36
- Revenue Next Year
- CRON $15.66
- CSTL N/A
- P/E Ratio
- CRON N/A
- CSTL $135.05
- Revenue Growth
- CRON 30.31
- CSTL 62.43
- 52 Week Low
- CRON $1.86
- CSTL $16.97
- 52 Week High
- CRON $3.14
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- CRON 43.81
- CSTL 39.09
- Support Level
- CRON $1.90
- CSTL $27.51
- Resistance Level
- CRON $2.00
- CSTL $32.57
- Average True Range (ATR)
- CRON 0.06
- CSTL 1.55
- MACD
- CRON -0.00
- CSTL -0.23
- Stochastic Oscillator
- CRON 34.78
- CSTL 17.49
About CRON Cronos Group Inc. Common Share
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.